Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.090
-0.050 (-1.59%)
At close: Jun 26, 2026, 4:00 PM EDT
3.500
+0.410 (13.27%)
After-hours: Jun 26, 2026, 5:14 PM EDT
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$163,652
Profits / Employee
-$212,087
Market Cap
25.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Vistagen Therapeutics | 59 |
| Kyntra Bio | 34 |
| Plus Therapeutics | 28 |
| NeuroSense Therapeutics | 17 |
| Serina Therapeutics | 16 |
| CervoMed | 15 |
| Barinthus Biotherapeutics | 14 |
EVAX News
- 15 days ago - Evaxion receives Prix Galien UK Award for Best digital health solution - GlobeNewsWire
- 16 days ago - Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia - GlobeNewsWire
- 6 weeks ago - Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress - GlobeNewsWire
- 7 weeks ago - Evaxion Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Evaxion Earnings release: Q1 2026 - Filings
- 7 weeks ago - Evaxion Slides: Q1 2026 - Filings
- 7 weeks ago - Evaxion announces business update and first quarter 2026 financial results - GlobeNewsWire
- 7 weeks ago - Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 - GlobeNewsWire